Also a peek at their plans for the year ahead. The post How 5 Psychedelics Companies Fared in 2022 appeared first on Green Market Report.
The article Top 5 Psychedelic Milestones of 2022 was originally published on Microdose. As we turn the final pages of 2022, it’s important to take a...
As psychedelic-assisted therapies near FDA approval, questions remain about cost, who's paying, and how much it saves patients and insurers in the long...
Drug overdoses in the United States have risen sharply in the last two decades. Nearly 92,000 people died from overdoses of illegal drugs and prescription...
'Tis the season to enhance your loved ones mind-altering experiences with just the right psychedelically inspired gift. The post A Holiday Gift Guide for...
The drug development company inspires psychedelics experts, but struggles to raise funds for its ketamine-assisted therapies and addiction treatments. The...
Awaken Life Sciences is trying to ride out a tough market for investment capital and raise funds for its ketamine-assisted therapies and addiction treatments. The...
Insurance coverage would expand access for the expensive treatments. The post Medical Insurance Providers Assess Benefits of Psychedelics Treatments appeared...
Enthea, the first provider of insurance plans for psychedelic healthcare, announces today its successful $2M seed round raise, led by Tabula Rasa Ventures,...
Bigger, broader trials are coming. The post Future of Psychedelics Therapy Requires Broader Clinical Trials appeared first on Green Market Report.